LIVING CARE PHARMACY (ILKLEY) LIMITED

Company Registration Number:
10263764 (England and Wales)

Unaudited abridged accounts for the year ended 17 March 2023

Period of accounts

Start date: 01 July 2022

End date: 17 March 2023

LIVING CARE PHARMACY (ILKLEY) LIMITED

Contents of the Financial Statements

for the Period Ended 17 March 2023

Balance sheet
Notes

LIVING CARE PHARMACY (ILKLEY) LIMITED

Balance sheet

As at 17 March 2023


Notes

9 months to 17 March 2023

2022


£

£
Fixed assets
Intangible assets: 3 0 703,966
Tangible assets: 4 0 267,204
Total fixed assets: 0 971,170
Current assets
Stocks: 133,282 130,168
Debtors:   79,790 298,594
Cash at bank and in hand:   3,012
Total current assets: 213,072 431,774
Creditors: amounts falling due within one year:   (362,766) (1,304,052)
Net current assets (liabilities): (149,694) (872,278)
Total assets less current liabilities: (149,694) 98,892
Creditors: amounts falling due after more than one year:     (31,589)
Provision for liabilities:   (12,769)
Total net assets (liabilities): (149,694) 54,534
Capital and reserves
Called up share capital: 100 100
Other reserves: 0 40,500
Profit and loss account: (149,794) 13,934
Shareholders funds: (149,694) 54,534

The notes form part of these financial statements

LIVING CARE PHARMACY (ILKLEY) LIMITED

Balance sheet statements

For the year ending 17 March 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 14 August 2024
and signed on behalf of the board by:

Name: Daniel Lee
Status: Director

The notes form part of these financial statements

LIVING CARE PHARMACY (ILKLEY) LIMITED

Notes to the Financial Statements

for the Period Ended 17 March 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

LIVING CARE PHARMACY (ILKLEY) LIMITED

Notes to the Financial Statements

for the Period Ended 17 March 2023

2. Employees

9 months to 17 March 2023 2022
Average number of employees during the period 8 10

LIVING CARE PHARMACY (ILKLEY) LIMITED

Notes to the Financial Statements

for the Period Ended 17 March 2023

3. Intangible Assets

Total
Cost £
At 01 July 2022 703,966
Revaluations (703,966)
At 17 March 2023 0
Net book value
At 17 March 2023 0
At 30 June 2022 703,966

LIVING CARE PHARMACY (ILKLEY) LIMITED

Notes to the Financial Statements

for the Period Ended 17 March 2023

4. Tangible Assets

Total
Cost £
At 01 July 2022 287,358
Disposals (287,358)
At 17 March 2023 0
Depreciation
At 01 July 2022 20,154
Charge for year 1,828
On disposals (21,982)
At 17 March 2023 0
Net book value
At 17 March 2023 0
At 30 June 2022 267,204